PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 50 filers reported holding PROQR THRAPEUTICS N V in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | +90.0% | 14,689 | +124.9% | 0.00% | – |
| Q2 2023 | $10 | -94.5% | 6,530 | -92.4% | 0.00% | – |
| Q1 2023 | $183 | +40.8% | 86,152 | +143.6% | 0.00% | – |
| Q4 2022 | $130 | -87.0% | 35,365 | +1347.6% | 0.00% | – |
| Q3 2022 | $1,000 | – | 2,443 | +5581.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 43 | -99.7% | 0.00% | – |
| Q4 2021 | $130,000 | -83.9% | 16,291 | -86.7% | 0.00% | -100.0% |
| Q1 2021 | $807,000 | +6625.0% | 122,183 | +3990.5% | 0.00% | – |
| Q4 2020 | $12,000 | – | 2,987 | +18568.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 16 | -99.1% | 0.00% | – |
| Q2 2020 | $11,000 | -91.8% | 1,853 | -92.4% | 0.00% | – |
| Q1 2020 | $134,000 | – | 24,484 | +24384.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | +92.3% | 0.00% | – |
| Q1 2019 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |